Top

Published in:

01-03-2006 | Original Article

Glomerular expression of transforming growth factor–β (TGF-β) isoforms in mice lacking CD2-associated protein

Authors: Robert P. Woroniecki, Mario Schiffer, Andrey S. Shaw, Frederick J. Kaskel, Erwin P. Bottinger

Published in: Pediatric Nephrology | Issue 3/2006

Abstract

Mice lacking CD2-associated protein (CD2AP−/−) develop glomerular lesions resembling human focal segmental glomerulosclerosis (FSGS) between 3–4 weeks of age and die approximately 2 weeks later from massive proteinuria and renal failure. The mechanisms involved in the glomerular injury in this model are unclear. In this study, we used laser capture microdissection (LCM) and real-time PCR, and examined expression of TGF-ß isoforms in CD2AP−/− mice at the level of isolated glomeruli. Total RNA yield from cryosections of 30 glomeruli was 10.71 ng (SD, 5.45) in CD2AP+/+ group (n =7), and 4.20 ng (SD, 2.04) in CD2AP−/− group (n =8), p =0.008. Expression of TGF-ß1 mRNA was increased 1.5-fold in the whole kidney (p =0.030), and twofold in isolated CD2AP−/− glomeruli (p =0.026). Whole kidney mRNA of TGF-ß receptor I (RI) and II (RII) was not different in CD2AP−/− and CD2AP+/+ animals, but it was increased in CD2AP−/− glomerular samples by 4.38-fold (p =0.001) and 11.37-fold (p =0.0163), respectively. By using LCM we confirmed increased glomerular expression levels of TGF-ß isoforms previously described by our group in glomeruli isolated by sieving in CD2AP KO mice and underscored the importance of local factors in the development of glomerulosclerosis.

Warady BA, Hebert D, Sullivan EK, Alexander SR, Tejani A (1997) Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 11:49–64CrossRefPubMed

Braden GL (2000) Changing incidence of glomerular diseases in adults. Am J Kidney Dis 35(5):878–883PubMed

Kriz W, Lemley KV (1999) The role of the podocyte in glomerulosclerosis. Curr Opin Nephrol Hypertens 8(4):489–497CrossRefPubMed

Hattori M, Horita S, Yoshioka T, Yamaguchi Y, Kawaguchi H, Ito K(1997) Mesangial phenotypic changes associated with cellular lesions in primary focal segmental glomerulosclerosis. Am J Kidney Dis 30:632–638PubMed

Mundel P, Shankland SJ (2002) Podocyte biology and response to injury. J Am Soc Nephrol 13:3005–3015CrossRefPubMed

Kim YH, Goyal M, Kurnit D, Wharram B, Wiggins J, Holzman L, Kershaw D, Wiggins R (2001) Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 60:957–968CrossRefPubMed

Dustin ML, Olszowy MW, Holdorf AD, Li J, Bromley S, Desai N, Widder P, Rosenberger F, van der Merwe PA, Allen PM, Shaw AS (1998) A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell 94:667–677CrossRefPubMed

Shih NY, Li J, Karpitskii V, Nguyen A, Dustin ML, Kanagawa O, Miner JH, Shaw AS (1999) Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 286:312–315CrossRefPubMed

Kim JM, Wu H, Green G, Winkler CA, Kopp JB, Miner JH, Unanue ER, Shaw AS (2003) CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300:1298–1300CrossRefPubMed

10.

Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, Shaw AS, Holzman LB, Mundel P (2001) Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 108:1621–1629CrossRefPubMed

11.

Huber TB, Hartleben B, Kim J, Schmidts M, Schermer B, Keil A, Egger L, Lecha RL, Borner C, Pavenstadt H, Shaw AS, Walz G, Benzing T (2003) Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 23:4917–4928CrossRefPubMed

12.

Sporn MB, Roberts AB (1988) Peptide growth factors are multifunctional. Nature 332:217–219CrossRefPubMed

13.

Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E (1990) Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 346:371–374CrossRefPubMed

14.

Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA (1993) Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814–1818PubMed

15.

Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE, Thorgeirsson SS (1996) Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 74:991–1003PubMed

16.

Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P, Mundel P, Bottinger EP (2001) Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 108:807–816CrossRefPubMed

17.

Bottinger EP, Bitzer M (2002) TGF-beta signaling in renal disease. J Am Soc Nephrol 13:2600–2610CrossRefPubMed

18.

Schiffer M, Mundel P, Shaw AS, Bottinger EP (2004) A novel role for the adaptor molecule CD2-associated protein in TGF-beta-induced apoptosis. J Biol Chem 279:37004–37012CrossRefPubMed

19.

Bonner RF, Emmert-Buck M, Cole K, Pohida T, Chuaqui R, Goldstein S, Liotta LA (1997) Laser capture microdissection: Molecular analysis of tissue. Science 278:1481–1483CrossRefPubMed

20.

Kohda Y, Murakami H, Moe OW, Star RA (2000) Analysis of segmental renal gene expression by laser capture microdissection. Kidney Int 57:321–331CrossRefPubMed

21.

Peterson KS, Huang JF, Zhu J, D’Agati V, Liu X, Miller N, Erlander MG, Jackson MR, Winchester RJ (2004) Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest 113:1722–1733CrossRefPubMed

22.

Schiffer M, Wu DT, Soto-Nieves N, Yu L, Shaw AS, Bottinger EP (2002) Phenotype characterization and gene expression profiling in CD2AP-knockout mice. J Am Soc Nephrol 13:43ACrossRef

23.

Craven RA, Totty N, Harnden P, Selby PJ, Banks RE (2002) Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis. Evaluation of tissue preparation and sample limitations. Am J Pathol 160:815–822PubMed

24.

Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP (2004) Integration of TGF-beta/Smad and jagged1/notch signalling in epithelial-to-mesenchymal transition. EMBO J 23:1155–1165CrossRefPubMed

25.

Morrissey J, Guo G, Moridaira K, Fitzgerald M, McCracken R, Tolley T, Klahr S (2002) Transforming growth factor-beta induces renal epithelial jagged-1 expression in fibrotic disease. J Am Soc Nephrol 13:1499–1508CrossRefPubMed

Title: Glomerular expression of transforming growth factor–β (TGF-β) isoforms in mice lacking CD2-associated protein
Authors: Robert P. Woroniecki
Mario Schiffer
Andrey S. Shaw
Frederick J. Kaskel
Erwin P. Bottinger
Publication date: 01-03-2006
Publisher: Springer-Verlag
Published in: Pediatric Nephrology / Issue 3/2006
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-005-2102-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Glomerular expression of transforming growth factor–β (TGF-β) isoforms in mice lacking CD2-associated protein

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2006

Laparoscopic adrenalectomy of an adrenal adenoma with myelolipoma relieves severe hypertension in a 16-year-old patient

Teaching molecular genetics: Chapter 2—Transgenesis and gene targeting: mouse models to study gene function and expression

Carbon monoxide prevents apoptosis induced by uropathogenic Escherichia coli toxins

E. coli virulence factors in children with neurogenic bladder associated with bacteriuria

Persistent secondary hyperparathyroidism after renal transplantation in children

Severe renovascular hypertension in an infant with congenital solitary pelvic kidney